Alterations in the catalytic activity of 69-kDa ChAT are found in a number of neurological disorders, including Alzheimer's disease (AD) (Pakaski and Kalman, 2008), amyotrophic lateral sclerosis (Kato, 1989) and Huntington's disease (Lange et al., 1992). Here, CHAT is linked to Huntington disease.